[go: up one dir, main page]

WO2003043627A1 - New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma - Google Patents

New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma Download PDF

Info

Publication number
WO2003043627A1
WO2003043627A1 PCT/IN2001/000203 IN0100203W WO03043627A1 WO 2003043627 A1 WO2003043627 A1 WO 2003043627A1 IN 0100203 W IN0100203 W IN 0100203W WO 03043627 A1 WO03043627 A1 WO 03043627A1
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
unique
asmakure
asthma
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2001/000203
Other languages
French (fr)
Other versions
WO2003043627A8 (en
Inventor
Tapan Kumar Chatterjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002503669A priority Critical patent/CA2503669A1/en
Priority to AU2002214251A priority patent/AU2002214251A1/en
Priority to PCT/IN2001/000203 priority patent/WO2003043627A1/en
Publication of WO2003043627A1 publication Critical patent/WO2003043627A1/en
Anticipated expiration legal-status Critical
Publication of WO2003043627A8 publication Critical patent/WO2003043627A8/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9064Amomum, e.g. round cardamom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Definitions

  • Asmakure is distinctive in its formulation as it covers all mediators acting as broncho-constrictors while other prevalent herbal medicines largely aim at only single mediator called leukotrienes. Asmakure , thus goes to the root of asthmatic disorder and eliminates it in a unique manner. Further.with regular use of Asmakure, patients who are on oral steroid therapy, inhaled steroids and bronchodilators or in extreme cases on inhaled adrenoreceptor agonists etc. , would gradually find themselves weaned away from the use thereof. All these unique features of Asmakure constitute its field of invention as a unique medicine.
  • Asthma is an inflammatory disorder of respiratory system with breathing difficulties.
  • drugs available in the modern medicines (steroid, ⁇ adrenoreceptor agonist, mast cell stabilizer, brochodilator) to treat asthma. All the modern drugs have restriction of their treatment due to their high toxicity. And none of them are curative medicines for treating asthma. After a prolonged period of extensive research, our group of scientists have ultimately invented one unique anti asthmatic drug which has no side effect. Clinically it has been revealed that this new invention has positive curative value in asthma treatment.
  • asthma is defined as a chronic inflammatory disorder of the airways
  • a herbal based drug with ingredients which have known properties for expectorant action and promoting expulsion of bronchial secretions. Further aided by ingredients having carminative and astringent properties, Asmakure has ability to offer complete curative treatment for people suffering not only from Asthma but also builds up complete and full immunity against comman cough and cold.
  • Raw materials were procured from authentic sources.
  • Phytochemical tests for checking the raw materials Chemical tests for carbohydrates , tannins , alkaloids , anthraquinones , fixed oils and fats , volatile oils and resins , were performed. Morphological and anatomical studies were carried out with the different parts of the material. For powdered drugs, microscopical examinations were done. Thus through the phytochemical tests , quality of the herb materials was authenticated.
  • Fresh leaves of the plant Adhatoda Vasica were collected in the month of Oct-nov.
  • the leaves were washed with double distilled water (with preservative to check any microbial contamination) and dried leaves were grinded in a pulverizer and passed through the mesh # 100.
  • the grinded leaves powder were then extracted in a soxhlet extractor with water and alcohol at pH 6.5.
  • the extracted materials were then dried in a spray drier.
  • the specification of the leaf extract is as follows:
  • the sieved nine powdered herb materials (e.g. talishpatra, ada, golmorich, Bara-elaichi, dachini, Pipul , nisadal, etc.) were separately weighed and mixed thoroughly in a Double Cone Mixture (National Engg. Make) for 15 minutes (20-24 rotation/min). Properly mixed material was then collected in a closed container to avoid catching of moisture from the environment. Bulk density of the material was calculated (0.451 gm/cc) following the standard methods. The room temperature was maintained at 24 ⁇ 1° C before filling.
  • the powdered mixture was then filled into bottles by semi-automatic powder filling machine.
  • the filled bottles were transferred to a bottle sealing machine. After sealing , they were transferred to an automatic Capping machine and labeling machine.
  • QC Testing The sample was taken at random from the sealed bottles for QC testing like phytochemical test, pharmaceuticakl test (water content, etc).

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Asthma is defined as a chronic inflammatory disorder of the airways of the respiratory organ. It is characterized by reversible airflow obstruction causing cough, wheeze, chest lightness and shortness of breath. The inflammation of bronchial wall together with increased eosinophilis and other inflammatory products of the mast cells and lymphocytes further induce the hyper responsiveness of the bronchi so that it in turn, narrows more rapidly in response to a wide range of stimuli. Asmakure the anti-asthma drug has properties with proven pharmacological use for alleviating common cold and persistent cough and finally building up of immunity against recurrence of Asthma. One of the ingredients Adhatoda Vasica Nees (Basak) has a definite expectorant action. In acute bronchitis, it is found to afford immediate relief especially when the sputum is thick and tenacious. The depression of the Vagal terminals further relieves irritation and spasm of the bronchioles.

Description

NEW ANTI-ASTHMATIC DRUG (ASMAKURE) FROM INDIGENOUS HERBS TO CURE THE DISEASE ASTHMA
FIELD OF INVENTION
The conventional treatment of asthma is mostly focused on managing the disease rather than finding a permanent solution to the problem . Asmakure is distinctive in its formulation as it covers all mediators acting as broncho-constrictors while other prevalent herbal medicines largely aim at only single mediator called leukotrienes. Asmakure , thus goes to the root of asthmatic disorder and eliminates it in a unique manner. Further.with regular use of Asmakure, patients who are on oral steroid therapy, inhaled steroids and bronchodilators or in extreme cases on inhaled adrenoreceptor agonists etc. , would gradually find themselves weaned away from the use thereof. All these unique features of Asmakure constitute its field of invention as a unique medicine.
BACKGROUND OF INVENTION WITH REGARD TO THE DRAWBACK OF ASSOCIATED WITH KNOWN ART
Asthma is an inflammatory disorder of respiratory system with breathing difficulties. There are some drugs available in the modern medicines (steroid, β adrenoreceptor agonist, mast cell stabilizer, brochodilator) to treat asthma. All the modern drugs have restriction of their treatment due to their high toxicity. And none of them are curative medicines for treating asthma. After a prolonged period of extensive research, our group of scientists have ultimately invented one unique anti asthmatic drug which has no side effect. Clinically it has been revealed that this new invention has positive curative value in asthma treatment.
DESCRIPTION OF THE INVENTION
Modern drugs have limited curative effect in the treatment of asthma as they hardly offer a permanent relief from the dreaded disease. Having seen the helplessness of the suffering humanity, we have finally come out with our research based anti-asthmatic drug, which is 100% natural and aims at complete control and elimination of the disease.
As asthma is defined as a chronic inflammatory disorder of the airways, we have now invented a herbal based drug with ingredients which have known properties for expectorant action and promoting expulsion of bronchial secretions. Further aided by ingredients having carminative and astringent properties, Asmakure has ability to offer complete curative treatment for people suffering not only from Asthma but also builds up complete and full immunity against comman cough and cold. DETAILED DESCRIPTION OF THE INVENTION WITH REFERENCES TO THE DRAWING
Procurement of raw materials :
Raw materials were procured from authentic sources. Phytochemical tests for checking the raw materials: Chemical tests for carbohydrates , tannins , alkaloids , anthraquinones , fixed oils and fats , volatile oils and resins , were performed. Morphological and anatomical studies were carried out with the different parts of the material. For powdered drugs, microscopical examinations were done. Thus through the phytochemical tests , quality of the herb materials was authenticated.
Process for leaf extract preparation of Adhatoda Vasica
Fresh leaves of the plant Adhatoda Vasica were collected in the month of Oct-nov. The leaves were washed with double distilled water (with preservative to check any microbial contamination) and dried leaves were grinded in a pulverizer and passed through the mesh # 100. The grinded leaves powder were then extracted in a soxhlet extractor with water and alcohol at pH 6.5. The extracted materials were then dried in a spray drier. The specification of the leaf extract is as follows:
1. Loss on drying
3.36% - 4.15
2. 60% Al. Soluble Extractives
89.62% -95%
3. Heavy Metals
Complies
4. Arsenic
Complies
5. Microbial Count
Complies
Total Alkaloids (By HPLC Method) 1.50%
Mixing:
The sieved nine powdered herb materials (e.g. talishpatra, ada, golmorich, Bara-elaichi, dachini, Pipul , nisadal, etc.) were separately weighed and mixed thoroughly in a Double Cone Mixture (National Engg. Make) for 15 minutes (20-24 rotation/min). Properly mixed material was then collected in a closed container to avoid catching of moisture from the environment. Bulk density of the material was calculated (0.451 gm/cc) following the standard methods. The room temperature was maintained at 24 ^1° C before filling.
The Powder filling in bottles :
The powdered mixture was then filled into bottles by semi-automatic powder filling machine.
Bottle sealing and labeling :
The filled bottles were transferred to a bottle sealing machine. After sealing , they were transferred to an automatic Capping machine and labeling machine.
QC Testing : The sample was taken at random from the sealed bottles for QC testing like phytochemical test, pharmaceuticakl test (water content, etc).

Claims

We claim -
Asmakure as a unique anti-asthmatic herbal formulation , the first of its kind in permanently curing asthma-the chronic inflammatory disorder of airways where the modern medicines have restrictive application due to their high toxicity. The herbal formulation Asmakure acts as a mast cell stabilizer along with bronchodilator. Due to dual mode of action , Asmakure is a unique antiasthmatic drug.
The formulation unique as claimed in claim 1 wherein as many as nine (9) different authentic herbs (medicinal plants and other natural products) in the dry condition have been mixed thoroughly to form dry-dry powder form to get maximum efficacy.
The formulation as unique as claimed in claims 1-2 wherein the mesh size (#) of the powder is uniformly kept below 20.
The formulation as unique as claimed in claims 1-3 wherein the solubility of the powder is kept above 75% w/v in water.
The formulation as unique as claimed in claims 1-4 wherein the bulk density of the powder is kept around 0.750 gm/cc.
The formulation as unique as claimed in claims 1-5 wherein the strict manufacturing process also ensures that the dry powder form remains below 4% (v/w) and its microbial count within limit.
The formulation as unique as claimed in claims 1-6 wherein the formulation contains the extract of A. Vasica with alkaloids concentration not less than 1.5% (total alkaloids).
Asmakure the research, based product, thus, has high efficacy in the treatment of asthma with no side -effect making it a unique formulation offering permanent relief to such patients.
PCT/IN2001/000203 2001-11-19 2001-11-19 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma Ceased WO2003043627A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002503669A CA2503669A1 (en) 2001-11-19 2001-11-19 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
AU2002214251A AU2002214251A1 (en) 2001-11-19 2001-11-19 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
PCT/IN2001/000203 WO2003043627A1 (en) 2001-11-19 2001-11-19 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000203 WO2003043627A1 (en) 2001-11-19 2001-11-19 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma

Publications (2)

Publication Number Publication Date
WO2003043627A1 true WO2003043627A1 (en) 2003-05-30
WO2003043627A8 WO2003043627A8 (en) 2006-08-24

Family

ID=11076410

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2001/000203 Ceased WO2003043627A1 (en) 2001-11-19 2001-11-19 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma

Country Status (3)

Country Link
AU (1) AU2002214251A1 (en)
CA (1) CA2503669A1 (en)
WO (1) WO2003043627A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007104985A1 (en) * 2006-03-16 2007-09-20 Nicholas John Larkins Compositions comprising apocynin , ginkgo and ginger and uses thereo
CN104474506A (en) * 2014-11-29 2015-04-01 黄根强 Traditional Chinese medicine composition for treating cough variant asthma
CN105012817A (en) * 2015-08-05 2015-11-04 陈瑜 Traditional Chinese medicine formula for relieving cough, relieving asthma and eliminating phlegm and preparing method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095993A (en) * 2017-06-19 2017-08-29 马绪梅 A kind of Chinese medicine for treating Respiratory Medicine bronchopulmonary aspergillosis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10113328A1 (en) * 2000-03-28 2001-11-15 Dabur Res Foundation Sahibabad New herbal composition for treating gynecological and other related disorders comprises solvent extracted herbal extract and a plant coagulate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10113328A1 (en) * 2000-03-28 2001-11-15 Dabur Res Foundation Sahibabad New herbal composition for treating gynecological and other related disorders comprises solvent extracted herbal extract and a plant coagulate

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHATTERJEE S: "BRONCHODILATORY AND ANTI-ALLERGIC EFFECT OF PULMOFLEX - A PROPRIETARY HERBAL FORMULATION", INDIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, ASSOCIATION OF PHYSIOLOGISTS AND PHARMACOLOGISTS, IN, vol. 43, no. 4, October 1999 (1999-10-01), pages 486 - 490, XP008007676, ISSN: 0019-5499 *
HERBICURE PRIVATE LIMITED: "Asmakure", HERBICURE (HOME PAGE), XP002216128, Retrieved from the Internet <URL:www.herbicureindia.com/Asmakure.asp> [retrieved on 20021009] *
KOHINOOR MANDAL: "Herbicure rejects US co's offer", BUSINESS LINE, FINANCIAL DAILY FROM THE HINDU GROUP OF PUBLICATIONS, 12 February 2002 (2002-02-12), XP002216127, Retrieved from the Internet <URL:www.blonnet.com/bline/2002/02/12/stories/2002021200670400.htm> [retrieved on 20021009] *
MATHUR ET AL: "Pulmoflex in Allergic Rhinitis", INDINA JOURNAL OF INDIGENOUS MEDICINES, vol. 17, no. 2, 1996, pages 25 - 29, XP001100058 *
UNI: "First Indian herbal company makes a debut with drug for asthma", DAILY EXCELSIOR, 11 February 2002 (2002-02-11), XP002216129, Retrieved from the Internet <URL:www.dailyexcelsior.com/02feb11/busi.htmA search with Google revealed that the product is already marketed "Asmakure-TM",> [retrieved on 20021009] *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007104985A1 (en) * 2006-03-16 2007-09-20 Nicholas John Larkins Compositions comprising apocynin , ginkgo and ginger and uses thereo
US8394423B2 (en) 2006-03-16 2013-03-12 Nicholas John Larkins Compositions comprising apocynin, ginkgo and ginger and uses thereof
CN104474506A (en) * 2014-11-29 2015-04-01 黄根强 Traditional Chinese medicine composition for treating cough variant asthma
CN105012817A (en) * 2015-08-05 2015-11-04 陈瑜 Traditional Chinese medicine formula for relieving cough, relieving asthma and eliminating phlegm and preparing method thereof

Also Published As

Publication number Publication date
AU2002214251A8 (en) 2003-06-10
AU2002214251A1 (en) 2003-06-10
WO2003043627A8 (en) 2006-08-24
CA2503669A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
CN101167749B (en) Preparing method for improving toad venom taste
SK90793A3 (en) Pharmaceutical compositions for the treatment of skin disorders
CN100542585C (en) A pharmaceutical composition for external use with analgesic and anti-inflammatory effects
WO2018058261A1 (en) Traditional chinese medicine composition for treating psoriasis and preparation method thereof
GB2411114A (en) Botanical drug or dietary supplement for use in the treatment of Hepatitis C
Peixoto et al. Spray-dried extracts from Syzygium cumini seeds: physicochemical and biological evaluation
CN101904948A (en) Traditional Chinese medicine preparation of Xinzhongsheng pills and preparation method thereof
CN106491470A (en) A kind of Sanguis Draxonis extract cosmetics and preparation method thereof
CN104083549A (en) Application of rhizoma curculiginis extract in preparing anti-depression medicament
WO2003043627A1 (en) New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
CN106377463A (en) Hydrating toner composition free from preservatives
CN117379484B (en) Cattle and sheep pneumonia aerosol and preparation method and application thereof
Borquaye et al. Anti-inflammatory, antioxidant and total phenolic content of the ethanolic extracts of Celtis africana Burm. f
CN107213239B (en) Traditional Chinese medicine composition and preparation method and application thereof
EP3441076A1 (en) Pharmaceutical product for treating tumor and combined immune defect, and preparation and application thereof
CN106620541B (en) A kind of external medicine composition for treating chronic eczema and preparation method thereof
Asif et al. Exploring the topical gel of Thespesia populnea leaf extract for in vivo wound healing efficacy
Sagar et al. Therapeutic Study of Garlic Gel Formulation for Tongue Ulcer Healing
Paul et al. Formulation and evaluation of Polyherbal tablet by using Neem, Tulsi, Turmeric and Ginger extract
CN108295023B (en) Traditional Chinese medicine toothpaste and preparation method thereof
CN112089767A (en) Compound traditional Chinese medicine bacteriostatic agent, preparation method and application thereof
Sagar et al. Formulation and Evaluation of Garlic Gel for Tongue Ulcer
Holy et al. Evaluation of the effect of Xylopia aethiopica on renal function indices of rats
Rajavel et al. Wound-Healing Activity of Herbal Ointment Containing the Root Extracts of Astragalus propinquus in Sprague Dawley Rats
CN103446564A (en) Traditional Chinese medicine composition for antisepsis and antiinflammation and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 22/2003 UNDER (51) REPLACE THE EXISTING SYMBOLS BY "A61K 35/78, A61P 11/06, //(A61K35/78, 35:78)" UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE AND UNDER (57) PUBLISHED ABSTRACT REPLACED BY CORRECT ABSTRACT

WWE Wipo information: entry into national phase

Ref document number: 2503669

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP